CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Cryo-Touch IIIdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01681745
NCT01681745N/ACompleted
CompareCT.gov

Probe Configuration and Time-Temperature Dose Ranging for Understanding of Skin Lesion Effects

Pacira Pharmaceuticals, Inc·interventional·Posted Sep 10, 2012·Updated Jan 24, 2024

In Brief

A clinical study evaluating Cryo-Touch III for Histological Response of Tissue to Cold. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This study is designed to characterize the biological response of the epidermis, dermis and subcutaneous tissue to treatment with the Myoscience Cryo-Touch III system.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHistological Response of Tissue to Cold
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 10, 2012
Enrollment StartJun 1, 2012
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 13.8 years ago

Interventions

Cryo-Touch IIIdevice